| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019868074 |
| P356 | DOI | 10.1007/S00380-016-0807-0 |
| P698 | PubMed publication ID | 26857388 |
| P5875 | ResearchGate publication ID | 293646616 |
| P2093 | author name string | Kenji Miyamoto | |
| Toshio Nakanishi | |||
| Tokuko Shinohara | |||
| Kei Inai | |||
| Daiji Takeuchi | |||
| P2860 | cites work | Biomarkers in heart failure | Q28280109 |
| Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank | Q31117253 | ||
| Congenital heart disease: the original heart failure syndrome | Q35114340 | ||
| Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease | Q35803749 | ||
| The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. | Q36610320 | ||
| Understanding diagnostic tests 3: Receiver operating characteristic curves | Q36765868 | ||
| Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology. | Q37470315 | ||
| Impact of spironolactone on endothelial function in patients with single ventricle heart | Q37535313 | ||
| Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study | Q37708944 | ||
| The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review | Q38047483 | ||
| Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. | Q38165436 | ||
| Biomarkers in adult congenital heart disease heart failure | Q38166116 | ||
| Serum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease | Q38861700 | ||
| Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 | ||
| Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease | Q44047539 | ||
| Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure | Q44589246 | ||
| Plasma catecholamine levels parallel severity of heart failure and have prognostic value in children with dilated cardiomyopathy | Q44648441 | ||
| Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease | Q45004569 | ||
| Relation of physical activity, cardiac function, exercise capacity, and quality of life in patients with a systemic right ventricle. | Q45940594 | ||
| Neurohormonal activation and its relation to outcomes late after repair of tetralogy of Fallot | Q46113455 | ||
| Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome | Q46693078 | ||
| Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation | Q46708880 | ||
| Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. | Q47920226 | ||
| Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease | Q48280472 | ||
| Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies | Q48348625 | ||
| B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy. | Q48625038 | ||
| Right ventricular function in grown-up patients after correction of congenital right heart disease | Q48779608 | ||
| Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation. | Q51050516 | ||
| Right and left ventricular volume characteristics after external conduit repair (Rastelli procedure) for cyanotic congenital heart disease | Q69620326 | ||
| Plasma cytokine parameters and mortality in patients with chronic heart failure | Q73306471 | ||
| Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease | Q73668684 | ||
| Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension | Q74206355 | ||
| Neurohormonal markers of clinical outcome in cardiovascular disease: is endothelin the best one? | Q77296325 | ||
| B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection | Q80168427 | ||
| Serum markers of systemic right ventricular function and exercise performance | Q80472810 | ||
| Associations between neurohormonal and inflammatory activation and heart failure in children | Q80758249 | ||
| B-type natriuretic peptide in patients with systemic right ventricle | Q81435956 | ||
| Hyponatremia and its association with the neurohormonal activity and adverse clinical events in children and young adult patients after the Fontan operation | Q83648609 | ||
| Aspirin resistance in adult patients after Fontan surgery | Q86197455 | ||
| Widespread endotheliopathy in adults with cyanotic congenital heart disease | Q87515742 | ||
| Association of interleukin-6 with the progression of carotid atherosclerosis: a 9-year follow-up study | Q87623736 | ||
| P433 | issue | 11 | |
| P921 | main subject | congenital heart disease | Q939364 |
| congenital disorder | Q727096 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 1834-1847 | |
| P577 | publication date | 2016-02-08 | |
| P1433 | published in | Heart and Vessels | Q15766690 |
| P1476 | title | Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles | |
| P478 | volume | 31 |
| Q30244374 | Burden of Heart Failure in Adults with Congenital Heart Disease |
| Q64067143 | Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients |
| Q51738848 | Clinical aspects of myocardial fibrosis in adults with Ebstein's anomaly. |
| Q38825516 | Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease |
| Q53065806 | Interventricular dyssynchrony in a patient with a biventricular physiology and a systemic right ventricle. |
| Q49487058 | Plasma endothelin-1-related peptides as the prognostic biomarkers for heart failure: A PRISMA-compliant meta-analysis |
| Q36388215 | Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk |
| Q90238724 | Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank |
Search more.